Molecular Templates Inc (MTEM)
0.4672
-0.14
(-23.41%)
USD |
NASDAQ |
Nov 15, 16:00
0.411
-0.06
(-12.03%)
After-Hours: 20:00
Molecular Templates Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | -19.06 |
December 31, 2022 | -2.390 |
September 30, 2022 | 8.656 |
June 30, 2022 | 1.370 |
March 31, 2022 | 0.7526 |
December 31, 2021 | 0.5405 |
September 30, 2021 | 0.4889 |
June 30, 2021 | 0.3595 |
March 31, 2021 | 0.1387 |
December 31, 2020 | 0.2515 |
September 30, 2020 | 0.1755 |
June 30, 2020 | 0.2635 |
March 31, 2020 | 0.0345 |
December 31, 2019 | 0.0363 |
September 30, 2019 | 0.0566 |
June 30, 2019 | 0.0344 |
March 31, 2019 | 0.0329 |
December 31, 2018 | 0.0322 |
September 30, 2018 | 0.0297 |
June 30, 2018 | 0.0493 |
Date | Value |
---|---|
March 31, 2018 | 0.0423 |
December 31, 2017 | 0.045 |
September 30, 2017 | 0.0464 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-19.06
Minimum
Mar 2023
8.656
Maximum
Sep 2022
-0.4411
Average
0.1387
Median
Mar 2021
Debt to Equity Ratio Benchmarks
Catheter Precision Inc | 0.0454 |
AIM ImmunoTech Inc | 0.4322 |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 0.7145 |
Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 26.70M |
Total Liabilities (Quarterly) | 19.59M |
Shareholders Equity (Quarterly) | 7.111M |
Current Ratio | 1.565 |
Net Debt Paydown Yield | 96.16% |